CIDP (chronic inflammatory demyelinating polyneuropathy): open trials in South Korea

• NCT05327114

  Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  Trial Treatment · Phase 2/3 · Janssen Research & Development, LLC

  KyungHee University Medical Center, Seoul · Konkuk University Medical Center, Seoul · Samsung Medical Center, Seoul

  Registry updated 2026-11-03

• NCT06920004

  A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

  Trial Treatment · Phase 3 · argenx

  Inje University Haeundae Paik Hospital, Busan · Seoul National University Hospital, Seoul · Konkuk University Medical Center, Seoul · Severance Hospital, Yonsei University Health System, Seoul

  Registry updated 2026-11-03

• NCT06858579

  A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

  Trial Treatment · Phase 3 · Dianthus Therapeutics

  Cinical Study Site, Daegu · Cinical Study Site, Daejeon · Cinical Study Site #3, Seoul · Cinical Study Site #2, Seoul · Cinical Study Site, Seoul · Cinical Study Site, Uijeongbu-si · Cinical Study Site, Yangsan

  Registry updated 2026-10-28

• NCT06859099

  Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP

  Trial Treatment · Phase 3 · Sanofi

  Investigational Site Number : 4100003, Seoul

  Registry updated 2026-10-27

• NCT07091630

  A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

  Trial Treatment · Phase 3 · argenx

  Seoul National University Hospital, Seoul · Korea University Guro Hospital, Seoul

  Registry updated 2026-10-27

All CIDP (chronic inflammatory demyelinating polyneuropathy) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error